-

Director/PDMR Shareholding

LONDON--(BUSINESS WIRE)-- 

UK REG TEST plc (the ‘Company’)

25 October 2023

Notification of Transactions of Directors

The Company was notified by Equiniti Financial Services Limited, that a Director acquired UK REG TEST plc ordinary shares of 614/81 pence (‘Shares’) in accordance with their Share Purchase Agreement held with the Company.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

UK REG TEST

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

UK REG TEST plc

b)

LEI

E26EDV109X6EEPBKVHXX

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 6 14/81 pence (Shares)

 

GB00B033FXXX

b)

Nature of the transaction

Acquisition of Shares in accordance with the Share Purchase Agreement entered into with the Company on 2 March 2022.

c)

Price(s) and volume(s)

Price(s)                Volume(s)

£ 1.574448            1,169

d)

Aggregated information

Total

 

£1,840.53

e)

Date of the transaction

25 October 2023

f)

Place of the transaction

London Stock Exchange (XLON)

UK REG TEST plc is listed on the London Stock Exchange (CNA)

Registered in England & Wales number: XXXXXXX

Legal Entity Identifier number: E26EDV109X6EEPBKVHXX

ISIN number: GB00B033FXXX

Category Code: DSH
Sequence Number: 599970
Time of Receipt (offset from UTC): 20231201T155727+0000

Contacts

UK REG TESTING

Industry:

UK REG TESTING

LSE:CNA

Release Versions

Contacts

UK REG TESTING

Back to Newsroom